Price movement over the last 24 hours
Agilent Technologies Inc vs TORM plc — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while TORM plc trades at $28.76 (market cap $2.87B). The key difference: Agilent Technologies Inc is far larger — about 12.9× TORM plc's market cap, and TORM plc pays the higher dividend (9.87%). Which is the better fit depends on your goals.
| A | TRMD | |
|---|---|---|
Market Cap | $37.04B | $2.87B |
Sector | Health | Technology |
52-Week High | $157.20 | $34.87 |
52-Week Low | $110.24 | $17.33 |
Enterprise Value | $38.59B | $3.76B |
Dividend Yield | 0.78% | 9.87% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TRMD trades at $27.99, up 1.05% today, with neutral technical signals and strong fundamentals. The stock shows attractive valuation metrics with P/E of 8.21 and P/B of 1.26, supported by robust profitability including 24.41% net margin and 15.62% ROE. Recent earnings showed mixed results with Q4 2025 beat but Q1 2026 miss, while Q2 2026 expectations are set at $3.3 EPS. The company maintains strong cash generation with $498.9M operating cash flow in 2025 and recently declared a $0.70 dividend.
Outlook remains positive with 100% analyst buy ratings and improving 2026 revenue guidance to $1.4B. Key opportunities include undervaluation relative to peers and strong dividend yield near 9%. Risks include earnings volatility from tanker market fluctuations and negative net cash flow trends. The stock presents value for income-focused investors despite cyclical industry exposure.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →